News | June 28, 2025
Shukra Pharmaceuticals receives LoA from RMSCL
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME
Star Health Insurance is modernising its claims ecosystem to be future-ready
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
Changhua site meets international regulatory standards for global medical applications
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Subscribe To Our Newsletter & Stay Updated
